FDA Commissioner Marty Makary has officially resigned after facing direct criticism from President Trump for stalling the approval of flavored e-cigarettes. This abrupt departure underscores a major clash between the agency’s regulatory pacing and the administration’s push to fulfill pro-vaping campaign pledges.
President Trump confirmed the resignation of the former Johns Hopkins surgeon on Tuesday. In a brief text-message resignation addressed to “Dr. President Trump,” Makary defended his tenure, citing 50 major FDA reforms, new guidance for psychedelics, and drastically reduced drug review times.
However, Makary made powerful enemies during his time in office. The breaking point reportedly centered on his resistance to market approvals for the vaping industry, a sector Trump heavily courted during his 2024 presidential campaign.
Makary’s tenure was derailed by several key controversies:
- Flavored Vape Delays: Makary blocked the implementation of a December approval for Glas, a California brand featuring Bluetooth “age-gated” technology to unlock nicotine vapor. The agency only proceeded after Trump’s direct intervention last week.
- Abortion Drug Backlash: Pro-life advocates, including Sen. Josh Hawley, accused Makary of stonewalling reviews of mifepristone and approving new abortion drugs that posed safety risks.
- Administration Friction: White House officials were reportedly infuriated by Makary providing funding to and hiring subordinates linked to left-leaning causes.
Following Trump’s direct reprimand regarding the vape approvals, the FDA announced plans on Friday to relax enforcement against e-cigarette manufacturers with pending product applications.
The debate over flavored vapes continues despite significant public health victories regarding youth addiction. Federal data shows a dramatic drop in teen usage since legislation raised the minimum purchase age to 21.
| National Youth Tobacco Survey Year | High School Past-Month Use | Middle School Past-Month Use |
|---|---|---|
| 2019 (Peak) | 27.5% | 10.5% |
| 2025 | 7.1% | 2.6% |
The battle over federal vaping regulations traces back to the first Trump administration, when flavor bans inadvertently fueled a black market of unregulated Chinese products. With Makary’s exit, the current administration appears poised to rapidly reshape the FDA’s approach to harm reduction and e-cigarette market access.
